<VariationArchive RecordType="classified" VariationID="1805433" VariationName="NM_006265.3(RAD21):c.1635del (p.Gly547fs)" VariationType="Deletion" Accession="VCV001805433" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-08-06" DateCreated="2022-12-24" MostRecentSubmission="2022-12-24">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1862445" VariationID="1805433">
      <GeneList>
        <Gene Symbol="RAD21" FullName="RAD21 cohesin complex component" GeneID="5885" HGNC_ID="HGNC:9811" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>8q24.11</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="116845934" stop="116874776" display_start="116845934" display_stop="116874776" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="117858172" stop="117887104" display_start="117858172" display_stop="117887104" Strand="-" />
          </Location>
          <OMIM>606462</OMIM>
          <Haploinsufficiency last_evaluated="2022-03-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=RAD21">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2022-03-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=RAD21">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_006265.3(RAD21):c.1635del (p.Gly547fs)</Name>
      <CanonicalSPDI>NC_000008.11:116849014:T:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>8q24.11</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="116849015" stop="116849015" display_start="116849015" display_stop="116849015" variantLength="1" positionVCF="116849014" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="117861254" stop="117861254" display_start="117861254" display_stop="117861254" variantLength="1" positionVCF="117861253" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>G547fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_772" sequenceAccession="LRG_772">
            <Expression>LRG_772:g.30852del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_772t1" sequenceAccession="LRG_772t1">
            <Expression>LRG_772t1:c.1635del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_772p1" sequenceAccession="LRG_772p1" change="p.Gly547Alafs">
            <Expression>LRG_772p1:p.Gly547Alafs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.10" sequenceAccession="NC_000008" sequenceVersion="10" change="g.117861254del" Assembly="GRCh37">
            <Expression>NC_000008.10:g.117861254del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.11" sequenceAccession="NC_000008" sequenceVersion="11" change="g.116849015del" Assembly="GRCh38">
            <Expression>NC_000008.11:g.116849015del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_032862.1" sequenceAccession="NG_032862" sequenceVersion="1" change="g.30852del">
            <Expression>NG_032862.1:g.30852del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006265.3" sequenceAccession="NM_006265" sequenceVersion="3" change="c.1635del" MANESelect="true">
            <Expression>NM_006265.3:c.1635del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_006256.1" sequenceAccession="NP_006256" sequenceVersion="1" change="p.Gly547fs">
            <Expression>NP_006256.1:p.Gly547fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_006265.3(RAD21):c.1635del (p.Gly547fs) AND Cornelia de Lange syndrome 4" Accession="RCV002471851" Version="1">
        <ClassifiedConditionList TraitSetID="8701">
          <ClassifiedCondition DB="MedGen" ID="C3553517">Cornelia de Lange syndrome 4</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-03-31" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-03-31" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-12-24" MostRecentSubmission="2022-12-24">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">31334757</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32193685</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32696056</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="8701" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17306" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Cornelia de Lange syndrome 4</ElementValue>
                <XRef ID="MONDO:0013864" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CORNELIA DE LANGE SYNDROME 4 WITH OR WITHOUT MIDLINE BRAIN DEFECTS</ElementValue>
                <XRef Type="MIM" ID="614701" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CDLS4</ElementValue>
                <XRef Type="MIM" ID="614701" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Cornelia de Lange syndrome (CdLS) encompasses a spectrum of findings from mild to severe. Severe (classic) CdLS is characterized by distinctive facial features, growth restriction (prenatal onset; &lt;5th centile throughout life), hypertrichosis, and upper-limb reduction defects that range from subtle phalangeal abnormalities to oligodactyly (missing digits). Craniofacial features include synophrys, highly arched and/or thick eyebrows, long eyelashes, short nasal bridge with anteverted nares, small widely spaced teeth, and microcephaly. Individuals with a milder phenotype have less severe growth, cognitive, and limb involvement, but often have facial features consistent with CdLS. Across the CdLS spectrum IQ ranges from below 30 to 102 (mean: 53). Many individuals demonstrate autistic and self-destructive tendencies. Other frequent findings include cardiac septal defects, gastrointestinal dysfunction, hearing loss, myopia, and cryptorchidism or hypoplastic genitalia.</Attribute>
                <XRef ID="NBK1104" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301283</ID>
                <ID Source="BookShelf">NBK1104</ID>
              </Citation>
              <XRef ID="199" DB="Orphanet" />
              <XRef ID="C3553517" DB="MedGen" />
              <XRef ID="MONDO:0013864" DB="MONDO" />
              <XRef Type="MIM" ID="614701" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5413750" SubmissionDate="2022-12-21" DateLastUpdated="2022-12-24" DateCreated="2022-12-24">
        <ClinVarSubmissionID localKey="vcgs/unit_1/hg38_NM_006265_2_RAD21_c_1635delA" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002766845" DateUpdated="2022-12-24" DateCreated="2022-12-24" Type="SCV" Version="1" SubmitterName="Victorian Clinical Genetics Services, Murdoch Childrens Research Institute" OrgID="500104" OrganizationCategory="laboratory" OrgAbbreviation="VCGS" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="508197" SubmitterName="Shariant Australia, Australian Genomics" Type="behalf" OrganizationCategory="consortium" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-03-31">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">31334757</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">32193685</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">32696056</ID>
          </Citation>
          <Comment>Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with Cornelia de Lange syndrome 4 (MIM#614701). (I) 0107 - This gene is associated with autosomal dominant disease. (I) 0115 - Variants in this gene are known to have variable expressivity (PMID: 31334757, PMID: 32193685). (I) 0205 - Variant is predicted to result in a truncated protein (premature termination codon is NOT located at least 54 nucleotides upstream of the final exon-exon junction) with less than 1/3 of the protein sequence affected. (SP) 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0600 - Variant is located in the annotated SMC1A domain (PMID: 32193685). (I) 0702 - Other truncating variants comparable to the one identified in this case have strong previous evidence for pathogenicity. These variant has been reported multiple times as pathogenic and likely pathogenic, and have been reported in individuals with holoprosencephaly or Cornelia de Lange (CdL). These variants have been described as de novo, or were inherited from an affected parent (DECIPHER, PMID: 32193685, PMID: 32696056). (SP) 0802 - This variant has moderate previous evidence of pathogenicity in unrelated individuals. This variant has been reported as pathogenic (LOVD) and observed in a single individual with CdL where the variant was de novo (PMID: 32193685). (SP) 0905 - No published segregation evidence has been identified for this variant. (I) 1007 - No published functional evidence has been identified for this variant. (I) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RAD21" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">ALLELE_13744</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_006265.2:c.1635delA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="614701" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>submission_38</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5413750" TraitType="Disease" MappingType="XRef" MappingValue="614701" MappingRef="OMIM">
        <MedGen CUI="C3553517" Name="Cornelia de Lange syndrome 4" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

